Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6492 | 0.84 | TSHR (0.39) | TSHRNFKB1CYP2C19 | |
| Hypochlorous Acid SCHEMBL15633664 | 0.82 | TSHR (0.40) | TSHRNFKB1CYP2C19 | |
| SCHEMBL1082541 | 0.80 | TSHR (0.43) | TSHRNFKB1CYP2C19 | |
| SCHEMBL2363259 | 0.80 | TSHR (0.43) | TSHRNFKB1CYP2C19 | |
| Hno SCHEMBL15954661 | 0.79 | TSHR (0.37) | TSHRNFKB1CYP2C19 | |
| SCHEMBL6567522 | 0.79 | TSHR (0.34) | TSHRNFKB1CYP2C19 | |
| Phosphoric Acid SCHEMBL6824270 | 0.78 | TSHR (0.38) | TSHRNFKB1CYP2C19 | |
| Succinic Acid SCHEMBL6263521 | 0.77 | TSHR (0.42) | TSHRNFKB1CYP2C19SMN1; SMN2 | |
| SCHEMBL5084504 | 0.77 | TSHR (0.35) | TSHRNFKB1CYP2C19 | |
| SCHEMBL4959307 | 0.77 | TSHR (0.33) | TSHRNFKB1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9035054-B2 | Dinitroxide-type biradical compounds optimized for dynamic nuclear polarization (DNP) | UNIVERSITE D'AIX-MARSEILLE (FR) | 2015-05-19 | — | — | US | disclosed |
| US-8648193-B2 | Dinitroxide-type biradical compounds optimized for dynamic nuclear polarization (DNP) | UNIVERSITE D'AIX MARSEILLE (FR) | 2014-02-11 | — | — | US | disclosed |
| EP-2411390-B1 | DINITROXIDE BIRADICAL COMPOUNDS OPTIMIZED FOR DYNAMIC NUCLEAR POLARIZATION (DNP) | UNIV AIX MARSEILLE (FR) | 2014-01-29 | — | — | EP | disclosed |
| US-20100249386-A1 | DINITROXIDE-TYPE BIRADICAL COMPOUNDS OPTIMIZED FOR DYNAMIC NUCLEAR POLARIZATION (DNP) | UNIVERSITE DE PROVENCE (FR) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249386-A1 | DINITROXIDE-TYPE BIRADICAL COMPOUNDS OPTIMIZED FOR DYNAMIC NUCLEAR POLARIZATION (DNP) | NME4, NDC1, MT-ND4L | TSHR 4069/4885NFKB1 347/4885CYP2C19 3409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.